Beyond Air Ltd   Report issue

For profit Phase 2
Founded: Garden City NY United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2019
NCT04060979
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Beyond Air | Beyond Air Inc. | Beyond Air Ltd

Active Ingredients

Drugs in Phase 2 Trials (1)

nitric oxide (inomax) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchiolitis (Phase 2)

Coronavirus Infections (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Respiration Disorders (Phase 2)

Respiratory Tract Diseases (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1